Nutrition Management Services Company (NMSCA) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of Nutrition Management Services Company $0.00, price $0.00, upside +0.0%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Nutrition Management Services Company for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range $0.0001 – $0.1000 · fair‑value band $0.0003 – $0.0003 · the $0.0003 price screens below the $0.0003 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Nutrition Management Services in your weekly email
Every Wednesday you see whether Nutrition Management Services is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Nutrition Management Services Company provides food, nutrition, and facilities management services in the United States. The company offers environmental management support solutions and cook/chill operation services.
Show more
Nutrition Management Services Company provides food, nutrition, and facilities management services in the United States. The company offers environmental management support solutions and cook/chill operation services. It serves long-term care facilities, independent and assisted living facilities, continuing care retirement communities, acute care hospitals, rehabilitation centers, and psychiatric and chemical dependency facilities, as well as nursing care centers and private schools. The company was founded in 1979 and is based in Kimberton, Pennsylvania.
Stock analysis
Nutrition Management Services Company (NMSCA) currently trades at $0.0003, while our model-based Fair Value estimate is $0.0003, so the stock looks roughly fairly valued today (gap 0.0%).
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of $0.0003 per share, and 3 of the 13 models we run sit above the $0.0003 price.
Bear case: the Earnings-Based group reads lowest at $0.0001, and 10 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.0003 (bear) to $0.0003 (bull), the price of $0.0003 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Nutrition Management Services Company reported revenue of $20.0M in FY2009 versus $26.6M in FY2005, a compound −6.9%/yr. Reported net income was $85.4K in FY2009, compounding −42.4%/yr from FY2005.
Key figures
Market cap $854 · Net margin 0.4% · Return on equity 4.0% · Return on assets (EBIT) −3.2% · Operating margin 4.5% · Revenue (TTM) $19.5M · Revenue growth (YoY) −9.3% · Free cash flow −$431K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 200% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 0%, NMSCA screens richer than that median.
Fair Value models
Bear $0.0003Fair Value $0.0003Bull $0.0003
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.6/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−4.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.5%
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.4%
’98
’99
’00
’01
’02
’03
’04
’05
’06
’07
’08
’09
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−35.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−35.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−35.7% vs −0.1%, slowing
Profit margin 2004 to 2009 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−3% → 2%
⚠ Revenue per share shrinking 5.4%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Compare Nutrition Management Services Company with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 246 stocks
Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score49 · Below median
Fair Value upside+0.0% · Below median
Profitability
Return on equity (TTM)4.0% · Below median
Return on assets2.8% · Below median
Net margin (TTM)0.7% · Bottom 25%
Operating margin (TTM)4.5% · Below median
Growth and dividend
Revenue growth−9.3% · Bottom 25%
Balance sheet
Debt / equity0.60× · Highest 25%
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Nutrition Management Services Company Fair Value". https://www.fairvalue-calculator.com/stock/NMSCA
Frequently asked questions
Is Nutrition Management Services Company (NMSCA) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0003 versus the last price from Sep 25, 2026 of $0.0003, about +0% upside (fairly valued).
What is the fair value of NMSCA?
Our model-based fair value for Nutrition Management Services Company is $0.0003 (as of Sep 27, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.0003.
What is the quality score of NMSCA?
Nutrition Management Services Company has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nutrition Management Services Company (NMSCA)?
Our model-based price target is the fair value of $0.0003 (as of Sep 27, 2026) from 13 valuation models. Cautious scenario $0.0003, optimistic scenario $0.0003. It is a calculation from audited fundamentals, not an analyst target.
What is the Nutrition Management Services Company stock forecast for 2026?
Our models put fair value at $0.0003, about +0% upside versus the last price from Sep 25, 2026 of $0.0003 (fairly valued). Cautious scenario $0.0003, optimistic scenario $0.0003. The calculation is refreshed regularly with new filings.
What is the revenue of Nutrition Management Services Company (NMSCA)?
Nutrition Management Services Company reported trailing-twelve-month revenue of about $19.5M (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Nutrition Management Services Company (NMSCA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nutrition Management Services Company it is $0.0003 per share (as of Sep 27, 2026), against a price of $0.0003. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Nutrition Management Services Company stock overvalued or undervalued in 2026?
As of Sep 27, 2026, NMSCA trades below its calculated fair value: price $0.0003, fair value $0.0003, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NMSCA?
No. The price is what the market pays today ($0.0003); the fair value is what the company's own numbers justify ($0.0003). For Nutrition Management Services Company the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nutrition Management Services Company worth?
The market values Nutrition Management Services Company at about $854 (market capitalisation, as of Sep 27, 2026). Per share that is $0.0003; our models calculate a fair value of $0.0003 per share.
What do the bullish and bearish scenarios say about NMSCA?
Our models span a range for Nutrition Management Services Company: cautious scenario $0.0003, base $0.0003, optimistic $0.0003 per share (as of Sep 27, 2026, price $0.0003). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nutrition Management Services Company (NMSCA)?
Balance-sheet figures for Nutrition Management Services Company (as of Sep 27, 2026): return on equity 4.0%, debt of 0.60 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is NMSCA from its 52-week high?
Nutrition Management Services Company trades at $0.0003, at its 52-week high of $0.0003 and 200% above the low of $0.0001 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0003 is for.
Which stocks are comparable to Nutrition Management Services Company?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nutrition Management Services Company stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0003, calculated fair value $0.0003 (+0%), Quality Score 49/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NMSCA calculated?
We run Nutrition Management Services Company through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0003, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Nutrition Management Services Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nutrition Management Services Company (NMSCA)?
The latest price we hold is from Sep 25, 2026 and stands at $0.0003. Our model-based fair value is $0.0003, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nutrition Management Services Company right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0003 to $0.0003), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Nutrition Management Services Company
How large is the market capitalisation of Nutrition Management Services Company (NMSCA)?
The market capitalisation of Nutrition Management Services Company is $854. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the net margin of Nutrition Management Services Company (NMSCA)?
The net margin of Nutrition Management Services Company is 0.4% (fiscal year 2009). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nutrition Management Services Company (NMSCA)?
The return on equity (ROE) of Nutrition Management Services Company is 4.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nutrition Management Services Company (NMSCA)?
On an EBIT basis the return on assets of Nutrition Management Services Company is −3.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nutrition Management Services Company (NMSCA)?
The operating margin of Nutrition Management Services Company is 4.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nutrition Management Services Company (NMSCA)?
Revenue at Nutrition Management Services Company is growing −9.3% versus a year earlier (3y avg −5.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Nutrition Management Services Company (NMSCA) generate?
The free cash flow of Nutrition Management Services Company is −$431K (fiscal year 2009). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Nutrition Management Services Company (NMSCA) carry?
The net debt of Nutrition Management Services Company is $5.2M (fiscal year 2009). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Nutrition Management Services Company in the live analysis
One click puts Nutrition Management Services Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026